Annual Total Liabilities
$6.87 M
-$5.26 M-43.35%
December 31, 2023
Summary
- As of March 9, 2025, CRVS annual total liabilities is $6.87 million, with the most recent change of -$5.26 million (-43.35%) on December 31, 2023.
- During the last 3 years, CRVS annual total liabilities has fallen by -$6.51 million (-48.67%).
- CRVS annual total liabilities is now -94.70% below its all-time high of $129.56 million, reached on December 31, 2015.
Performance
CRVS Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Liabilities
$46.41 M
+$33.07 M+248.00%
September 30, 2024
Summary
- As of March 9, 2025, CRVS quarterly total liabilities is $46.41 million, with the most recent change of +$33.07 million (+248.00%) on September 30, 2024.
- Over the past year, CRVS quarterly total liabilities has increased by +$38.75 million (+506.38%).
- CRVS quarterly total liabilities is now -64.18% below its all-time high of $129.56 million, reached on December 31, 2015.
Performance
CRVS Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
CRVS Total Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -43.4% | +506.4% |
| 3 y3 years | -48.7% | +282.7% |
| 5 y5 years | -13.0% | +282.7% |
CRVS Total Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -44.1% | at low | at high | +590.6% |
| 5 y | 5-year | -48.7% | at low | at high | +590.6% |
| alltime | all time | -94.7% | at low | -64.2% | +892.9% |
Corvus Pharmaceuticals Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $46.41 M(+248.0%) |
| Jun 2024 | - | $13.34 M(+98.4%) |
| Mar 2024 | - | $6.72 M(-2.2%) |
| Dec 2023 | $6.87 M(-43.3%) | $6.87 M(-10.2%) |
| Sep 2023 | - | $7.65 M(-10.6%) |
| Jun 2023 | - | $8.56 M(-8.3%) |
| Mar 2023 | - | $9.33 M(-23.1%) |
| Dec 2022 | $12.13 M(-1.4%) | $12.13 M(-22.6%) |
| Sep 2022 | - | $15.67 M(+28.9%) |
| Jun 2022 | - | $12.15 M(+5.1%) |
| Mar 2022 | - | $11.57 M(-5.9%) |
| Dec 2021 | $12.29 M(-8.1%) | $12.29 M(-13.3%) |
| Sep 2021 | - | $14.18 M(+9.1%) |
| Jun 2021 | - | $12.99 M(-12.5%) |
| Mar 2021 | - | $14.85 M(+11.0%) |
| Dec 2020 | $13.38 M(+6.7%) | $13.38 M(-1.0%) |
| Sep 2020 | - | $13.51 M(+1.3%) |
| Jun 2020 | - | $13.34 M(-3.1%) |
| Mar 2020 | - | $13.76 M(+9.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2019 | $12.54 M(+58.8%) | $12.54 M(+4.0%) |
| Sep 2019 | - | $12.06 M(-10.4%) |
| Jun 2019 | - | $13.46 M(+15.9%) |
| Mar 2019 | - | $11.61 M(+47.1%) |
| Dec 2018 | $7.90 M(-20.6%) | $7.90 M(-5.7%) |
| Sep 2018 | - | $8.38 M(-20.4%) |
| Jun 2018 | - | $10.52 M(-8.2%) |
| Mar 2018 | - | $11.46 M(+15.3%) |
| Dec 2017 | $9.94 M(+35.3%) | $9.94 M(-10.1%) |
| Sep 2017 | - | $11.05 M(+3.2%) |
| Jun 2017 | - | $10.71 M(+20.6%) |
| Mar 2017 | - | $8.88 M(+20.8%) |
| Dec 2016 | $7.35 M(-94.3%) | $7.35 M(+7.2%) |
| Sep 2016 | - | $6.85 M(+38.4%) |
| Jun 2016 | - | $4.95 M(+6.0%) |
| Mar 2016 | - | $4.67 M(-96.4%) |
| Dec 2015 | $129.56 M(+921.1%) | $129.56 M(+2.1%) |
| Sep 2015 | - | $126.94 M |
| Dec 2014 | $12.69 M | - |
FAQ
- What is Corvus Pharmaceuticals annual total liabilities?
- What is the all time high annual total liabilities for Corvus Pharmaceuticals?
- What is Corvus Pharmaceuticals annual total liabilities year-on-year change?
- What is Corvus Pharmaceuticals quarterly total liabilities?
- What is the all time high quarterly total liabilities for Corvus Pharmaceuticals?
- What is Corvus Pharmaceuticals quarterly total liabilities year-on-year change?
What is Corvus Pharmaceuticals annual total liabilities?
The current annual total liabilities of CRVS is $6.87 M
What is the all time high annual total liabilities for Corvus Pharmaceuticals?
Corvus Pharmaceuticals all-time high annual total liabilities is $129.56 M
What is Corvus Pharmaceuticals annual total liabilities year-on-year change?
Over the past year, CRVS annual total liabilities has changed by -$5.26 M (-43.35%)
What is Corvus Pharmaceuticals quarterly total liabilities?
The current quarterly total liabilities of CRVS is $46.41 M
What is the all time high quarterly total liabilities for Corvus Pharmaceuticals?
Corvus Pharmaceuticals all-time high quarterly total liabilities is $129.56 M
What is Corvus Pharmaceuticals quarterly total liabilities year-on-year change?
Over the past year, CRVS quarterly total liabilities has changed by +$38.75 M (+506.38%)